Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Beard hair loss can signal early diabetes and thyroid issues, treatable with specific cream.

Use antiandrogens and other treatments for hair loss.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

Adding nano fat to hair transplants improves results for scar-related hair loss.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Current treatments for alopecia show no significant long-term benefits.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Abnormal cuticle and hair shaft medulla cause hair loss in androgenetic alopecia; sonography helps diagnose and manage it.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Most hair loss in children is caused by a few common conditions and is easy to diagnose, but rare types require careful evaluation.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.